Orchid Pharma informs about disclosure

16 Jun 2021 Evaluate
Orchid Pharma has informed about disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Approval for Reclassification of Shareholders of Orchid Pharma ('the Company') from the 'Promoter and Promoter Group' category to 'Public' category under Regulation 31A of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

689.80 -16.95 (-2.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×